New Cousteau-Linked...
Health Care: Drugs
Arena Pharmaceuticals Inc. (ARNA: NASDAQ)
$6.43 0.03 | 0.47%
06/04/12 - 04:00 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -109.22M | -124.53M | -153.20M | -237.57M |
| Operating Gains/Losses | 10.48M | 7.97M | -2.63M | -37.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 2.88M | -1.93M | 430.00K | 61.00K |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -1.12M | -5.64M | -28.76M | 14.34M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | -3.58M | 43.84M | -92.00K | -100.00K |
| Other Non-Cash Items | 10.20M | 13.28M | 14.86M | 12.57M |
| Net Cash From Continuing Operations | -78.26M | -52.32M | -155.92M | -191.44M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -78.26M | -52.32M | -155.92M | -191.44M |
| Sale of Property, Plant & Equipment | 33.00K | 47.00K | 263.00K | 38.00K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 21.66M | 36.70M | 39.12M |
| Purchases of Property, Plant & Equipment | -619.00K | -4.21M | -5.33M | -42.79M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | -1.23M | -20.43M | -65.02M |
| Other Cash from Investing Activities | -86.00K | 48.00K | 170.00K | 179.00K |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -672.00K | 16.32M | 11.36M | -68.47M |
| Issuance of Debt | 0.00 | 0.00 | 111.86M | 1.00M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 35.64M | 120.47M | 65.37M | 1.73M |
| Repayment of Long-Term Debt | -49.80M | -30.72M | -10.58M | -240.00K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | -55.83M |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | -14.16M | 89.75M | 166.65M | -53.34M |
| Effect of Exchange Rate Changes | 50.00K | 2.18M | -688.00K | -407.00K |
| Net Change in Cash & Cash Equivalents | -93.04M | 55.94M | 21.40M | -313.66M |
Portfolios with ARNA
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- Userchrisnash69 Portfolio 1
- User1st Time out
- Userbio
- UserWIDELY HELD IN GAME
- Usermarket watch 2012
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- UserHoldings
- ContributorStocks Under-$10 Moving Hig...
Latest ARNA Headlines from TheStreet
- Stocks Under $10: Why I'm a Buyer
05.31.12 | 07:05 am - 4 Stocks Under $10 Making Big Moves 05.30.12 | 03:05 pm
- Arena Pharmaceuticals Inc. (ARNA): Today's Featured Health Care Loser 05.25.12 | 05:05 pm
- Biotech Stock Mailbag: ASCO, Celldex, Obesity Drug Game-Changer 05.25.12 | 05:05 am
- Outlooks for Pfizer, Arena and Onyx Following Busy May 05.21.12 | 07:05 am
- Biotech Stock Live Chat Recap: ASCO & Obesity 05.17.12 | 11:05 am
- Stocks Under $10: Healthcare Name on Sale 05.17.12 | 07:05 am
- Hot Biotech Stocks Traded by Hedge Funds in First Quarter 05.16.12 | 07:05 am
- Arena Pharmaceuticals Inc. (ARNA): Today's Featured Health Care Winner 05.14.12 | 04:05 pm
- Mulling Arena Pharma's Future With Obesity Drug on Approval Path 05.14.12 | 03:05 pm
Press Releases for ARNA
- Arena Pharmaceuticals Investigated By Goldfarb Branham Law Firm LLP - Business Wire 10.08.10 | 09:10 am
- Girard Gibbs LLP Files Class Action Lawsuit Against Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) - Business Wire 09.29.10 | 05:09 pm
- Lieff Cabraser Heimann & Bernstein, LLP Announces Class Action Lawsuits Against Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) - Business Wire 09.28.10 | 02:09 pm
- Investor Notice: The Rosen Law Firm Announces Filing Of Securities Class Action Against Arena Pharmaceuticals, Inc. - ARNA - Business Wire 09.22.10 | 06:09 pm
- Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Arena Pharmaceuticals, Inc. - Business Wire 09.22.10 | 05:09 pm
- The Law Office Of Robbins Umeda LLP Announces An Investigation Of Arena Pharmaceuticals, Inc. - Business Wire 09.22.10 | 12:09 pm
Partner Headlines for ARNA
- Vivus' Qnexa Is Not Guaranteed Approval. Remember Provenge? - Benzinga 05.31.12 | 12:05 pm
- 4 Smaller Alternatives to Big Pharma Obesity Treatments - Benzinga 05.25.12 | 01:05 pm
- Pre-Market Most Active for May 22, 2012 : QQQ, NOK, FB, BBY, TEF, BAC, SNY, NVO, VOD, AAPL, ARNA, ZNGA - NASDAQ 05.22.12 | 12:05 pm
- Pre-Market Most Active for May 17, 2012 : SNY, BAC, BUD, MT, MTL, WMT, QQQ, VOD, AAPL, DNDN, ZNGA, ARNA - NASDAQ 05.17.12 | 12:05 pm
- Pre-Market Most Active for May 16, 2012 : CTL, SNY, BAC, GE, NCT, MT, QQQ, ARNA, SINA, PETD, ZNGA, RIMM - NASDAQ 05.16.12 | 12:05 pm
- After Hours Most Active for May 15, 2012 : DFG, TPX, JCP, GSM, QQQ, BAC, ARNA, CCJ, AIG, VELT, INTC, NWSA - NASDAQ 05.15.12 | 08:05 pm
- Pre-Market Most Active for May 14, 2012 : BAC, CHK, NOK, BBVA, CS, SIRI, JPM, ARNA, QQQ, YHOO, AAPL, FRAN - NASDAQ 05.14.12 | 12:05 pm
- Arena Pharmaceuticals: FDA Approval Is Just The Beginning - Seeking Alpha 05.13.12 | 09:05 am
- Benzinga's Top Upgrades with Color for May 11, 2012 - Benzinga 05.11.12 | 12:05 pm
- Social Media Outlook for Wednesday May 9 (PDC, DIS, STEC, FOSL) - Benzinga 05.09.12 | 01:05 pm
